Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas

Coordinate Regulation of TET2 and EBNA2 Controls the DNA Methylation State of Latent Epstein-Barr Virus

(2017) Fang Lu et al.   JOURNAL OF VIROLOGY

MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs

(2017) A R Pyzer et al.   LEUKEMIA

JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework

(2017) Aziz Khan et al.   NUCLEIC ACIDS RESEARCH

Three-dimensional biomimetic vascular model reveals a RhoA, Rac1, andN-cadherin balance in mural cell–endothelial cell-regulated barrier function

(2017) Stella Alimperti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells

(2017) Laura V. Glaser et al.   PLoS Pathogens

CD274 (PD-L1)/PDCD1 (PD-1) expression in de novo and transformed diffuse large B-cell lymphoma

(2016) Anna Kwiecinska et al.   BRITISH JOURNAL OF HAEMATOLOGY

High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma

(2016) Sara Correia Marques et al.   EXPERIMENTAL HEMATOLOGY

Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency

(2016) Coral K. Wille et al.   JOURNAL OF VIROLOGY

MYC regulates the antitumor immune response through CD47 and PD-L1

(2016) S. C. Casey et al.   SCIENCE

miR-34 activity is modulated through 5′-end phosphorylation in response to DNA damage

(2016) David W. Salzman et al.   Nature Communications

EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-jκ and EBF1

(2016) Fang Lu et al.   PLoS Pathogens

Classical Hodgkin Lymphoma with Reduced  2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status

(2016) M. G. M. Roemer et al.   Cancer Immunology Research

Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma

(2015) J. Kiyasu et al.   BLOOD

miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer

(2015) B. D. Adams et al.   CANCER RESEARCH

The Inescapable Influence of Noncoding RNAs in Cancer

(2015) B. D. Adams et al.   CANCER RESEARCH

Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

(2015) Padmanee Sharma et al.   CELL

Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia

(2015) Xi Wang et al.   CELLULAR SIGNALLING

Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas

(2015) Dohee Kwon et al.   HISTOPATHOLOGY

Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cells

(2015) Eleni Anastasiadou et al.   INTERNATIONAL JOURNAL OF CANCER

Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis

(2015) Caterina Veroni et al.   Journal of Neuroinflammation

The future of immune checkpoint therapy

(2015) P. Sharma et al.   SCIENCE

Fresh Insights into Disease Etiology and the Role of Microbial Pathogens

(2015) Antonella Farina et al.   Current Rheumatology Reports

Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: An immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells

(2013) Arianna Di Napoli et al.   PEDIATRIC BLOOD & CANCER

Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro

(2013) D.-H. T. Nguyen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration

(2012) H. Thorvaldsdottir et al.   BRIEFINGS IN BIOINFORMATICS

miRNA-34 Prevents Cancer Initiation and Progression in a Therapeutically Resistant K-ras and p53-Induced Mouse Model of Lung Adenocarcinoma

(2012) A. L. Kasinski et al.   CANCER RESEARCH

Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy

(2012) M. R. Green et al.   CLINICAL CANCER RESEARCH

Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo

(2012) V J Craig et al.   LEUKEMIA

Differential regulation of miR-21 and miR-146a by Epstein–Barr virus-encoded EBNA2

(2012) P Rosato et al.   LEUKEMIA

miR-34 – a microRNA replacement therapy is headed to the clinic

(2012) Andreas G. Bader   Frontiers in Genetics

MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma

(2011) Soichiro Yamamura et al.   CARCINOGENESIS

Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth

(2011) B. Zhao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia

(2010) Olaf Merkel et al.   CELL CYCLE

An ATM/Chk2-Mediated DNA Damage-Responsive Signaling Pathway Suppresses Epstein-Barr Virus Transformation of Primary Human B Cells

(2010) Pavel A. Nikitin et al.   Cell Host & Microbe

MicroRNA-34a Perturbs B Lymphocyte Development by Repressing the Forkhead Box Transcription Factor Foxp1

(2010) Dinesh S. Rao et al.   IMMUNITY

Epstein–Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells

(2009) Eleni Anastasiadou et al.   CANCER LETTERS

MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes

(2009) Y. Li et al.   CANCER RESEARCH

The miR-34 family in cancer and apoptosis

(2009) H Hermeking   CELL DEATH AND DIFFERENTIATION

Epstein–Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b

(2009) E Anastasiadou et al.   ONCOGENE

Burkitt's lymphoma: The Rosetta Stone deciphering Epstein-Barr virus biology

(2009) Martin Rowe et al.   SEMINARS IN CANCER BIOLOGY